Obesity
Feature
Tirzepatide scores win in second obesity trial, SURMOUNT-2
Tirzepatide (Mounjaro) met its primary endpoints, compared with placebo, in the SURMOUNT-2 trial, designed to test weight-loss efficacy, in top-...
Latest News
BMI is a flawed measure of obesity. What are alternatives?
“BMI is trash. Full stop.”
Feature
Optimal time period for weight loss drugs: Debate continues
“Without the medicine, there are a variety of things that will happen. Appetite will tend to increase, and so [patients] will gradually tend to...
From the Journals
Use age, not weight, to screen for diabetes; assess over 35s
‘If we make decisions about diabetes testing based on weight, we will miss some people from racial and ethnic minority groups who are developing...
Latest News
Study offers dozens of reasons to cut sugar
The result is a list that cites the world’s most common health problems like heart disease, diabetes, obesity, high blood pressure, heart attack,...
Opinion
Time to rebuild
Latest News
Infant and maternal weight gain together amplify obesity risk
A new study finds monitoring infants for rapid weight gain is particularly important when mothers have elevated prepregnancy weight.
Commentary
New antiobesity drugs will benefit many. Is that bad?
Patients are regularly seen discontinuing or reducing the dosage of multiple medications as a result of improvements to multiple weight-responsive...
Commentary
What happens when newer weight loss meds are stopped?
Although these drugs are very effective for weight loss and treating diabetes, there can be adverse effects.
Latest News
Like mother, like daughter? Moms pass obesity risk to girls
The mother-daughter relationship for fat mass appears to be established by age 4 years.
Commentary
What’s the ‘secret sauce’ to help patients move more?
When surveyed about aerobic exercise and strength training, only 24.6% meet weekly recommendations.